Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...
Current use of hydroxychloroquine is associated with a lower risk for myocardial infarction (MI), stroke, and other thromboembolic events in patients with systemic lupus erythematosus (SLE). This ...
A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...
Background/objective To reduce the risk of hydroxychloroquine (HCQ)-induced retinopathy, the American Academy of ...
Use of hydroxychloroquine during pregnancy in patients with systemic lupus erythematosus (SLE) is associated with a reduced risk for preeclampsia, according to a recent nationwide cohort study. A ...
Hydroxychloroquine use may lower the risk for new-onset diabetes among patients with primary Sjögren syndrome. Hydroxychloroquine (HCQ) use significantly lowers the risk for new-onset diabetes among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results